Sarcoma trials in Sweden

In Sweden 13 Also abroad 605

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Gothenburg
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 3Taking people
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Where
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
Age
4 years and over
People
530 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864
Phase 3Taking people
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Where
Goteborg, Gothenburg, Linkoping, Lund, Solna, Stockholm, Umea, Uppsala
Age
Up to 64 years
People
1,351 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00
No phaseTaking people
Molecular and Clinical Studies of Bone and Soft Tissue Tumors
Where
Stockholm
People
50,000
Run by
Karolinska Institutet
See details and how to joinNCT07822204
Phase 2Taking people
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Where
Gothenburg, Lund, Stockholm
Age
18 years to 100 years
People
33 worldwide
Run by
Lund University Hospital
See details and how to joinNCT06389799 · EU 2022-501993-21-00
Phase 1Taking people
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
Where
Gothenburg
People
18 worldwide
Run by
GPOH gGmbH
See details and how to join2024-515245-42-00 · EU 2024-515245-42-00
Phase 1/2Taking people
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Where
Stockholm
Age
18 years and over
People
96 worldwide
Run by
Anocca AB
See details and how to joinNCT07145450
No phaseTaking people
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Where
Gothenburg
Age
18 years and over
People
100 worldwide
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441
No phaseEnrolling by invitation
Implant-Related Infections in Patients With Skeletal Sarcomas
Where
Gothenburg
People
40
Run by
Vastra Gotaland Region
See details and how to joinNCT07264296
No phaseEnrolling by invitation
Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.
Where
Stockholm
Age
15 years and over
People
300
Run by
Region Stockholm
See details and how to joinNCT06968884
Phase 1/2Taking people
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Where
Goteborg, Gothenburg, Lund, Solna, Umea, Uppsala, Linkoping University Hospital
People
1,672 worldwide
Run by
University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00
Phase 3Taking people
Use of GnRHa During Chemotherapy for Fertility Protection
Where
Goteborg, Gothenburg, Huddinge, Lund, Malmo, Orebro, Solna, Stockholm, Umea, Uppsala
Age
14 years to 42 years
People
500
Run by
Kenny Rodriguez-Wallberg
See details and how to joinNCT05328258 · EU 2024-518977-32-00
Phase 2Taking people
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Where
Solna
Age
18 years and over
People
80 worldwide
Run by
Niels Junker
See details and how to joinNCT05961761 · EU 2024-513727-16-00